Market Value140,138,000
Total Holdings75
File Date2017-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RIGL / Rigel Pharmaceuticals, Inc.
TMBR / Timber Pharmaceuticals Inc
EXAC / Exactech, Inc.
/ Array BioPharma, Inc.
45780VAB8 / Inotek Pharmaceuticals Corporation Bonds 5.75% 8/1/2021
SLS / SELLAS Life Sciences Group, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
LOXO / Loxo Oncology, Inc.
SGMO / Sangamo Therapeutics, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
ZGNX / Zogenix Inc
SRRA / Sierra Oncology Inc
AGTC / Applied Genetic Technologies Corp
RDUS / Radius Recycling, Inc.
ELOS / Syneron Medical Ltd.
JNJ / Johnson & Johnson
ABEO / Abeona Therapeutics Inc.
ALDR / Alder BioPharmaceuticals, Inc.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
RCKT / Rocket Pharmaceuticals, Inc.
CNAT / Conatus Pharmaceuticals Inc.
ANAB / AnaptysBio, Inc.
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
US00448Q2012 / Achillion Pharmaceuticals, Inc.
45784PAD3 / Insulet Corp. Bond
NERV / Minerva Neurosciences, Inc.
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
FOMX / Foamix Pharmaceuticals Ltd.
GEMP / Gemphire Therapeutics Inc.
NXTM / NxStage Medical, Inc.
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
US46333XAD03 / Ironwood Pharmaceuticals, Inc. DBCV 2.250% 6/1
OBSV / ObsEva SA.
NDRM / NeuroDerm Ltd.
ARQL / ArQule, Inc.
US64052L1061 / Neos Therapeutics, Inc.
252131AE7 / Dexcom Inc Bond
TRIL / Trillium Therapeutics Inc
VSCI /
24983LAA2 / Dermira Inc Bond
/ Immunomedics, Inc.
ADXS / Ayala Pharmaceuticals, Inc.
NTUS / Natus Medical Inc
US0906721065 / BioTelemetry, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
SPNC / Spectranetics Corp. (The)
DERM / Journey Medical Corporation
CYAD / Celyad Oncology - ADR
ADMP / Adamis Pharmaceuticals Corp
MGNX / MacroGenics, Inc.
TNXP / Tonix Pharmaceuticals Holding Corp.
CASC / Cascadian Therapeutics, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
CARA / Cara Therapeutics, Inc.
AERI / Aerie Pharmaceuticals Inc
ARNA / Arena Pharmaceuticals Inc
PDSB / PDS Biotechnology Corporation
AGLE / Aeglea BioTherapeutics Inc
VYGR / Voyager Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
FSTX / F-star Therapeutics Inc
STXS / Stereotaxis, Inc.
AKBA / Akebia Therapeutics, Inc.
ARDX / Ardelyx, Inc.
BLUE / bluebird bio, Inc.
QURE / uniQure N.V.
CBAY / CymaBay Therapeutics, Inc.
VIRX / Viracta Therapeutics, Inc.
AFMD / Affimed N.V.
CDTX / Cidara Therapeutics, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation
XENE / Xenon Pharmaceuticals Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
NBIX / Neurocrine Biosciences, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
AXSM / Axsome Therapeutics, Inc.
MASI / Masimo Corporation
ATRC / AtriCure, Inc.
PODD / Insulet Corporation
BCRX / BioCryst Pharmaceuticals, Inc.
TNDM / Tandem Diabetes Care, Inc.